Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01041235
What this trial is testing

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Who this might be right for
Solid TumorBreast CancerOvarian Cancer+2 more
Azaya Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT01222689
What this trial is testing

Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Ended earlyNCT06065059
What this trial is testing

Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors

Who this might be right for
Breast CancerOvarian CancerPancreas Cancer+5 more
Tango Therapeutics, Inc. 7
Early research (Phase 1)Study completedNCT00942682
What this trial is testing

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 21
Testing effectiveness (Phase 2)Looking for participantsNCT06861452
What this trial is testing

Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
EIR Biotherapies s.r.l. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07126158
What this trial is testing

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaCancer of the PancreasPancreas Cancer+1 more
Washington University School of Medicine 36
Very early researchUnknownNCT05438797
What this trial is testing

The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Sizhen Wang 3
Testing effectiveness (Phase 2)Study completedNCT00603863
What this trial is testing

Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Gilead Sciences 80
Testing effectiveness (Phase 2)UnknownNCT03316326
What this trial is testing

S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
National Taiwan University Hospital 35
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT00424827
What this trial is testing

A Trial of Chemo & Radiation Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Massachusetts, Worcester 11
Not applicableTemporarily Not AvailableNCT07319910
What this trial is testing

Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
NovoCure GmbH
Early research (Phase 1)Study completedNCT02559674
What this trial is testing

QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel

Who this might be right for
Advanced Pancreatic Cancer
Altor BioScience 8
Testing effectiveness (Phase 2)Study completedNCT00305760
What this trial is testing

Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Early research (Phase 1)Study completedNCT03086642
What this trial is testing

Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Karie D. Runcie, MD 10
Early research (Phase 1)Ended earlyNCT06704724
What this trial is testing

Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Who this might be right for
Carcinoma, Pancreatic DuctalColorectal NeoplasmsCarcinoma, Non-Small-Cell Lung
Pfizer 30
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06313970
What this trial is testing

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

Who this might be right for
Pancreatic Cancer
Fudan University 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04331041
What this trial is testing

Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma

Who this might be right for
Pancreas CancerCancer of the PancreasPancreas Adenocarcinoma
Washington University School of Medicine 42
Not applicableLooking for participantsNCT06600906
What this trial is testing

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal Adenocarcinoma
University of California, San Francisco 70
Next Page